UnitedHealth Group (UNH)
282.12
+1.06 (0.38%)
NYSE · Last Trade: Jul 29th, 1:03 AM EDT
Detailed Quote
Previous Close | 281.06 |
---|---|
Open | 283.50 |
Bid | 284.10 |
Ask | 284.15 |
Day's Range | 279.69 - 285.00 |
52 Week Range | 248.88 - 630.73 |
Volume | 15,788,022 |
Market Cap | 256.73B |
PE Ratio (TTM) | 11.81 |
EPS (TTM) | 23.9 |
Dividend & Yield | 8.840 (3.13%) |
1 Month Average Volume | 13,190,327 |
Chart
About UnitedHealth Group (UNH)
UnitedHealth Group is a leading diversified health and well-being company that provides a wide range of health care products and services. The company operates through two main segments: UnitedHealthcare, which offers health insurance and health services to individuals and businesses, and Optum, which delivers pharmacy care, health management, and technology solutions. UnitedHealth Group focuses on enhancing health care access, improving health outcomes, and optimizing costs through integrated care solutions and data-driven insights. With a commitment to innovation and quality, the company aims to help people live healthier lives while making the health care system work better for everyone. Read More
News & Press Releases
The healthcare giant's value has been in free fall this year as bad news continues to pile up.
Via The Motley Fool · July 28, 2025
NEW YORK, July 28, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, announces that a class action lawsuit has been filed against UnitedHealth Group Incorporated (“UnitedHealth” or the “Company”) (NYSE: UNH) in the United States District Court for the Southern District of New York on behalf of all persons and entities who purchased or otherwise acquired UnitedHealth securities between December 3, 2024 and April 16, 2025, both dates inclusive (the “Class Period”). Investors have until July 7, 2025 to apply to the Court to be appointed as lead plaintiff in the lawsuit.
By Bragar Eagel & Squire · Via GlobeNewswire · July 28, 2025
Shares of UnitedHealth Group Incorporated (NYSE: UNH) are trading lower Monday as investors took a cautious stance ahead of the company's upcoming second-quarter earnings report on Tuesday July 29.
Via Benzinga · July 28, 2025
UnitedHealth Says DOJ Investigating Its Medicare Billing Practicesstocktwits.com
Via Stocktwits · July 24, 2025
Centene Corporation (NYSE:CNC), a leading healthcare enterprise specializing in managed care services for government-sponsored health programs, has transformed itself over the past four decades from a small regional player into a national powerhouse. Headquartered in St. Louis, Missouri, Centene's rise has been defined by an aggressive acquisition strategy, targeted
Via MarketMinute · July 28, 2025
U.S. stock futures rose on Monday after ending higher on Friday. Futures of major benchmark indices were higher.
Via Benzinga · July 28, 2025
Health insurance company UnitedHealth (NYSE:UNH)
will be reporting results this Tuesday before market hours. Here’s what you need to know.
Via StockStory · July 27, 2025
Charter, Chipotle, and Fiserv led last week's large-cap declines amid earnings misses, downgrades, and cautious guidance.
Via Benzinga · July 27, 2025
Sci-fi becomes reality: AI-native pharma disruptors like Palantir, Tempus, and Recursion are reshaping medicine. But ETFs still favor old-school giants.
Via Benzinga · July 26, 2025
As previously announced, UnitedHealth Group will release its second quarter 2025 financial results on Tuesday, July 29, 2025, before the market opens. The start time for the teleconference has moved to 8:00 a.m. ET, 45 minutes earlier than previously announced, to allow more time for discussion of results with analysts and investors. This call will be webcast on the Investor Relations page of the company’s website (www.unitedhealthgroup.com). The replay will be available through August 12 on the website.
By UnitedHealth Group · Via Business Wire · July 25, 2025
Via The Motley Fool · July 25, 2025
On Thursday, the major averages closed on a mixed note, with a fall in weekly jobless claims and some positive earnings reports helping the S&P 500 Index and the Nasdaq Composite to hit fresh highs.
Via Stocktwits · July 25, 2025
U.S. stock futures showed mixed movements on Thursday, with the Dow Jones Industrial Average declining 0.7% to 44,693.91.
Via Benzinga · July 24, 2025
Bragar Eagel & Squire, P.C. Litigation Attorney Brandon Walker Encourages Investors Who Suffered Losses In UnitedHealth (UNH), Bitfarms (BITF), or Reddit (RDDT) To Contact Him Directly To Discuss Their Options
By Bragar Eagel & Squire · Via GlobeNewswire · July 24, 2025
Shares of life sciences company Neogen (NASDAQ:NEOG)
jumped 3.4% in the morning session after the company announced the appointment of Mike Nassif as its new Chief Executive Officer and President.
Via StockStory · July 24, 2025
Molina Healthcare missed Q2 EPS estimates and lowered its 2025 guidance, pressuring major health insurers including UnitedHealth and Centene.
Via Benzinga · July 24, 2025
UnitedHealth is cooperating with the DOJ on Medicare-related inquiries and has launched third-party reviews to ensure transparency and compliance.
Via Benzinga · July 24, 2025
New UNHG ETF offers 200% daily exposure to UnitedHealth Group with low expense ratio. Themes ETFs adds to roster with 20 single-stock leveraged ETFs.
Via Benzinga · July 23, 2025
The entire healthcare sector has fallen into a deeply discounted valuation, creating opportunities for investors who hunt for value and upside
Via MarketBeat · July 23, 2025
Oscar Health, Inc. (NYSE:OSCR) stands as a disruptive force in the American health insurance landscape, emerging as a pioneer at the crossroads of technology and healthcare. Since its inception in 2012, Oscar Health has sought to simplify, personalize, and digitize the insurance experience, aiming to reshape a sector often
Via MarketMinute · July 23, 2025
Oscar Health has once again asserted itself as a formidable disruptor in the insurance sector, with its stock posting robust gains after the company exceeded Wall Street’s expectations. The latest quarterly results for Oscar Health (NYSE:OSCR) showcased not only improving financial fundamentals but also a growing footprint in
Via MarketMinute · July 23, 2025
Shares of lab services company Charles River Laboratories (NYSE:CRL)
jumped 7.5% in the morning session after the company announced a plasmid DNA manufacturing agreement with Elly's Team, a parent-led foundation working to find a cure for a rare genetic disorder.
Via StockStory · July 22, 2025